Arcoma AB/ SE0006219176 /
| 2024-04-19 5:29:54 PM | Chg. -0.10 | Volume | Bid5:29:54 PM | Ask5:29:54 PM | High | Low |
|---|---|---|---|---|---|---|
| 11.60SEK | -0.85% | 8,235 Turnover: 95,566.25 |
11.60Bid Size: 2,042 | 11.70Ask Size: 3,019 | 11.65 | 11.55 |
GlobeNewswire
2023-11-29
Valo Therapeutics Announces Regulatory Approval to Expand Phase I Immuno-oncology Trial into Sarcoma
GlobeNewswire
2020-11-04
Oncternal Announces Third Quarter 2020 Financial Results and Provides Business Update
GlobeNewswire
2020-10-14
Arvinas Announces Pipeline Programs Targeting Validated and Classically “Undruggable” Disease-Causin...
GlobeNewswire
2019-06-25
Global Operating Tables Market Forecasts to 2022: Growing Trend toward Hybrid Operating Rooms Spurs ...
GlobeNewswire
2017-05-10
TRACON Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
GlobeNewswire
2017-04-10
TRACON Awarded ‘Most Innovative Trial Design’ for Phase 3 TAPPAS Clinical Trial of TRC105 in Angiosa...
GlobeNewswire
2017-02-28
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2016 Financial Results and Provides Corp...
